Impact Factor
2.86
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.45
253 total citations
h5-index
21
h5 depth signal
Cited share
65.9%
118 of 179
Total citations
253
Citation footprint
Metric signal
1.31
External metric anchor
Self-citation
5.9%
15 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
703
China
255
South Africa
77
Brazil
75
Italy
64
Citing Fields of Research
HIV
1,315
Immunology
106
Viral Identification & Phylogenetics
67
Hepatitis
39
Sexually Transmitted Diseases
35
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,694
Articles tracked across the journal lifetime
Indexed publication set
179
118 cited publications
Last 12 months
60
5.0 publications/month
Open access share
6.7%
4 OA publications in the last year
Leading citing country
United States
703 citing publications
Leading citing field
HIV
1,315 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v3n1,spring 1987-
v3n1,spring 1987-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
Acquired Immunodeficiency Syndrome
Retroviridae
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1177/08892229261491499
Open DOI
Revisiting What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications
In 2021, a Perspective article suggested that principles of HIV neuropathogenesis could provide a conceptual framework for understanding the neurological complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infec...
03
DOI 10.1177/08892229261490969
Open DOI
Safety of Autologous Infusion of CER T Cells in Nonhuman Primates
Cellular immunotherapies have shown great promise in the treatment of various diseases. Chimeric engulfment receptor (CER)-engineered T cells were developed to utilize the extracellular T-cell immunoglobulin and mucin domain-containing 4...
04
DOI 10.1177/08892229261495198
Open DOI
Willingness to Participate in HIV Cure Research Among Young People Living with Perinatally Acquired HIV in the Centre Region of Cameroon: A Cross-Sectional Survey
Young people living with perinatally acquired HIV (YPLHIV) represent a unique population for HIV cure research, offering opportunities to assess interventions in a group for whom adherence to antiretroviral treatment (ART) is particularl...
05
DOI 10.1177/08892229261491477
Open DOI
Experiences and Acceptability of Serial Lymph Node and Gut Biopsies Among Young Women Enrolled in an HIV Cure–Related Trial in Durban, South Africa
Human immunodeficiency virus (HIV) persists in diverse body tissues, including the gut, lymph nodes (LNs), and lungs, requiring direct sampling to characterize heterogeneous reservoirs. HIV cure–related trials may include tissue sampling...
06
DOI 10.1177/08892229261490627
Open DOI
Identification of Two Novel HIV-1 Unique Recombinant Forms Involving CRF07_BC and CRF08_BC Among ART-Failing Patients in Hebei, China
The continuous HIV-1 recombination forms circulating in China poses a persistent challenge to epidemic control. And this study identifies two novel unique recombinant forms (URFs), BDNY017 and BDK025, from antiretroviral therapy (ART)-fa...
07
DOI 10.1177/08892229261487810
Open DOI
The Effect of rs7975232 (ApaI) and rs731236 (TaqI) VDR Polymorphisms on HIV/AIDS Prevalence and Mortality: An International Population Genetics Analysis
In this study, the relationship between the allele and genotype frequencies of the rs7975232 (ApaI) and rs731236 (TaqI) polymorphisms of the vitamin D receptor ( VDR ) gene and country-based HIV/AIDS prevalence and mortality rates were e...
08
DOI 10.1177/08892229261487815
Open DOI
Clinical Factors Associated with Short-Term Decline in Estimated Glomerular Filtration Rate in People Living with HIV Receiving Antiretroviral Therapy: A Prospective Cohort Study
HIV infection remains a significant public health challenge. Although antiretroviral therapy has substantially improved survival, chronic complications such as renal impairment increase morbidity and mortality, making the estimated glome...
09
DOI 10.1177/08892229261480775
Open DOI
Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa
Several forms of HIV pre-exposure prophylaxis (PrEP) are approved, prescribed off-label, or in development in the United States, including daily oral tablets, long-acting injectable cabotegravir (CAB-LA), removable implants, and rectal t...
10
DOI 10.1177/08892229261479805
Open DOI
Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China
Despite over 40 years having passed since the discovery of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), neither a cure nor a prophylactic vaccine is yet clinically available. Promoting preventive measures...
Bibliographical & Catalog Notes
Title from cover.
Also available on the World Wide Web.
Continues: AIDS research.
Vol. 3, no. 1 (1987)19911012 Notice not published Printed on acid-free paper